EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

ANTIMALARIAL ACTIVITY OF THE DIFFERENT FRACTIONS OF THE ROOT EXTRACTS OF SALACIA NITIDA (BENTH) (CELASTRACEAE) ON PLASMODIUM BERGHEI INFECTION IN MICE

Dooka Barido Donatus* and Kagbo Hope Delesi

ABSTRACT

Background: Resistance to antimalarial agents is a major challenge in the treatment of malaria. The aim of the study was to evaluate the antimalarial activity of the root extract of Salacia nitida in Plasmodium berghei infection in mice. Method: The plant material was successively extracted with N-hexane, Dichloromethane, Ethyl acetate, and Methanol. In suppressive test Plasmodium berghei inoculated mice were randomly divided into eight groups of 5 mice each. Group 1, was treated with the vehicle (10 ml/kg distilled water), the treated groups received 100 and 200 mg / kg of DCM, Et Ac and MeOH respectively. Group VIII was treated with Artesunate 5 mg /kg. In the chemoprophylactic and curative test, the treated received 100,200 and 400 mg / kg. The variation in level of parasitemia, survival time and weight of the mice, were used to determine the activity of the extract. Results: In the suppressive test; 100 mg /kg of DCM, Et Ac. And Me OH activities were 25.58, 26.51 and 11.90% (P<0.05) and 200 mg/ kg. produced activities 63.95%, 28.83, 25.58% respectively and Artesunate 61.40% (p<0.05).In chemoprophylactic activities were: 38.02%, 55.97%, 71.81 and Artesunate 65.40% while curative activities were 28.16%, 31.36%, and 63.36% at doses of 100mg/kg, 200gm/kg, and 400mg/kg respectively of the Dichloromethane extract showed significant (p<0.05). Conclusion: The results of the study showed that the Dichloromethane root extract of Salacia nitida possesses good chemoprophylactic and moderate curative activity, which could be exploited in the search for malaria drugs.

Keywords: Antimalarial activity, Salacia nitida, Malaria, Plasmodium berghei, Mice.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here